US equities |
MU $968.12 ▲+4.24% META $612.61 ▼-1.22% SPCX $144.37 ▼-2.84% TSLA $401.70 ▼-1.41% NVDA $216.97 ▼-0.45% SNDK $1,379.51 ▲+5.72% GOOGL $325.23 ▲+1.45% SKHY $164.40 ▲+13.10%
FinancialContent

Celestica (NY:CLS)

299.46 +22.92 (+8.29%)
Delayed Quote Updated: 1:45 PM EDT, Oct 28, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Celestica

< Previous 1 2
...
11 12 13 14 15 16 17 18 Next >
News headline image
Mid-Afternoon Market Update: Nasdaq Tumbles 240 Points; Oragenics Shares Spike Higher ↗
Toward the end of trading Tuesday, the Dow traded down 0.50% to 34,969.30 while the NASDAQ fell 1.62% to 14,600.30. The S&P also fell, dropping 0.80% to 4,387.07. The U.S. has... 
Via Benzinga
Topics Stocks
News headline image
44 Stocks Moving In Tuesday's Mid-Day Session ↗
Gainers Oragenics, Inc. (NASDAQ: OGEN) surged 55.9% to $0.9749 after the company announced it entered into a licensing agreement with the National Research Council of Canada that... 
Via Benzinga
Could A Helium Shortage Derail The Tech Boom
Via FinancialNewsMedia
News headline image
Celestica Inc (CLS) Q1 2021 Earnings Call Transcript ↗
CLS earnings call for the period ending March 31, 2021. 
Via The Motley Fool
Topics Earnings
News headline image
Celestica Beats Q1 Earnings Despite Pandemic Impact, Issues Positive Q2 Guidance ↗
Celestica Inc (NYSE: CLS) reported a first-quarter FY21 revenue decline of 6% year-on-year to $1.23 billion, narrowly beating the consensus of $1.22 billion.... 
Via Benzinga
News headline image
Earnings Preview for Celestica ↗
On Wednesday, April 28, Celestica (NYSE:CLS) will release its latest earnings report. Here is Benzinga's outlook for the company. Net Income, Earnings, And Earnings Per Share... 
Via Benzinga
< Previous 1 2
...
11 12 13 14 15 16 17 18 Next >